Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Vellanki Avanish
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/11/2023
4
Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Oncology Inc.
Txns:
Granted 266,500 options to buy @ $1.21, valued at $322.5k
Granted 133,250 options to buy @ $1.21, valued at $161.2k
06/02/2022
4
Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2022
4
Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
Gifted 59,618 shares @ $0
Gifted 59,618 shares @ $0
03/15/2022
4
Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022
4
Vellanki Avanish (President and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
Granted 182,300 options to buy @ $8.02, valued at $1.5M
04/27/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021
3
Form 3 - Initial statement of beneficial ownership of securities:
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy